Key Insights

Highlights

Treatment Research

2 treatments under study, led by Heart Will Be Treated With Custodioln

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Suspended1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07381530Phase 2Suspended

Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children

Showing all 1 trials

Research Network

Common Treatments

  • Heart Will Be Treated With Custodioln1
  • Heart Will Be Treated With Custodiol1

Active Sponsors

  • Dr. F. Köhler Chemie GmbH1
  • Dr. Franz Koehler Chemie GmbH1

Top Investigators

Related Conditions

  • Congenital Heart Malformations1

Activity Timeline